![No image](https://static.cymitquimica.com/public/img/logo-cymit-gray.png)
CAS: 1308672-74-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Benzenemethanesulfonamide, N-[2-(dimethylamino)ethyl]-3-[[4-[(2-methyl-1H-indol-5-yl)oxy]-2-pyrimidinyl]amino]- REF: IN-DA000V1DCAS: 1308672-74-3 | 98% | 25.00 €~490.00 € | Mon 03 Mar 25 |
![]() | Sulfatinib REF: TM-T4075CAS: 1308672-74-3 | 100% - 98.93% | 47.00 €~354.00 € | Mon 05 May 25 |
![]() | Sulfatinib REF: 3D-ICC67274CAS: 1308672-74-3 | Min. 95% | - - - | Discontinued product |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Benzenemethanesulfonamide, N-[2-(dimethylamino)ethyl]-3-[[4-[(2-methyl-1H-indol-5-yl)oxy]-2-pyrimidinyl]amino]-
CAS:1308672-74-3
Formula:
C24H28N6O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
480.5825
Ref: IN-DA000V1D
5mg | 25.00 € | ||
10mg | 28.00 € | ||
25mg | 46.00 € | ||
50mg | 58.00 € | ||
100mg | 73.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Sulfatinib
CAS:1308672-74-3
Sulfatinib (KDR-IN-1) (HMPL-012) is a potent and highly selective tyrosine kinase inhibitor against VEGFR1/2/3, FGFR1 …
Formula:
C24H28N6O3S
Purity:
100% - 98.93%
Color and Shape:
Liquid
Molecular weight:
480.58
Ref: TM-T4075
1mg | 47.00 € | ||
5mg | 79.00 € | ||
10mg | 96.00 € | ||
25mg | 157.00 € | ||
50mg | 227.00 € | ||
100mg | 354.00 € | ||
1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Monday 5 May 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Sulfatinib
CAS:1308672-74-3
Sulfatinib is an inhibitor of the CDK4 and CDK6 protein, which are cell cycle regulators. …
Formula:
C24H28N6O3S
Purity:
Min. 95%
Molecular weight:
480.58 g/mol
Ref: 3D-ICC67274
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |